Programmed death-1 receptor (PD-1) and PD-ligand-1 (PD-L1) expression in non-small cell lung cancer and the immune-suppressive effect of anaerobic glycolysis | SpringerLink
In situ and in silico kinetic analyses of programmed cell death-1 (PD-1) receptor, programmed cell death ligands, and B7-1 protein interaction network - Journal of Biological Chemistry
IJMS | Free Full-Text | Tumors of the Nose and Paranasal Sinuses: Promoting Factors and Molecular Mechanisms—A Systematic Review
IJMS | Free Full-Text | Programmed Death Ligand 1 Indicates Pre-Existing Adaptive Immune Response by Tumor-Infiltrating CD8+ T Cells in Non-Small Cell Lung Cancer
The immune checkpoint B7-H3 (CD276) regulates adipocyte progenitor metabolism and obesity development | Science Advances
Mechanism of anti-programmed death 1 (PD-1) receptor and... | Download Scientific Diagram
Exploring the Effect of Halogenation in a Series of Potent and Selective A2B Adenosine Receptor Antagonists | Journal of Medicinal Chemistry
Fragment-based screening of programmed death ligand 1 (PD-L1) - ScienceDirect
Programmed cell death-1/programmed cell death ligand-1 checkpoint inhibitors: differences in mechanism of action | Immunotherapy
Programmed Death-Ligand 1 and Programmed Death-Ligand 2 mRNAs Measured Using Closed-System Quantitative Real-Time Polymerase Chain Reaction Are Associated With Outcome and High Negative Predictive Value in Immunotherapy-Treated NSCLC - ScienceDirect
Cancers | Free Full-Text | Programmed Death-Ligand 1 (PD-L1) as Immunotherapy Biomarker in Breast Cancer
Programmed Death 1 Ligand 1 - an overview | ScienceDirect Topics
Programmed death-ligand 1 - Libre Pathology
PD-1/PD-L1 checkpoint blockade harnesses monocyte-derived macrophages to combat cognitive impairment in a tauopathy mouse model | Nature Communications
Fragment-based screening of programmed death ligand 1 (PD-L1) - ScienceDirect
Programmed cell death-1/programmed cell death ligand-1 checkpoint inhibitors: differences in mechanism of action | Immunotherapy
IJMS | Free Full-Text | Programmed Death Ligand 1 Indicates Pre-Existing Adaptive Immune Response by Tumor-Infiltrating CD8+ T Cells in Non-Small Cell Lung Cancer
Programmed Death-Ligand 1 and Programmed Death-Ligand 2 mRNAs Measured Using Closed-System Quantitative Real-Time Polymerase Chain Reaction Are Associated With Outcome and High Negative Predictive Value in Immunotherapy-Treated NSCLC - ScienceDirect
Cancers | Free Full-Text | Long Non-Coding RNAs: Tools for Understanding and Targeting Cancer Pathways
Correlation between programmed cell death ligand 1 (PD-L1) and CD8 in... | Download Scientific Diagram
Programmed Death-Ligand 1 and Programmed Death-Ligand 2 mRNAs Measured Using Closed-System Quantitative Real-Time Polymerase Chain Reaction Are Associated With Outcome and High Negative Predictive Value in Immunotherapy-Treated NSCLC - ScienceDirect
Mechanisms for intratumoral programmed cell death ligand-1 (PD-L1)... | Download Scientific Diagram
Programmed death‑ligand 1 positivity can predict improved survival and a lower risk of brain metastasis in patients with resectable small cell lung cancer
IJMS | Free Full-Text | Programmed Death Ligand 1 Indicates Pre-Existing Adaptive Immune Response by Tumor-Infiltrating CD8+ T Cells in Non-Small Cell Lung Cancer
Programmed cell death protein receptor and ligands in haematological malignancies – Current status - ScienceDirect
Discordance of PD-L1 status between primary and metastatic breast cancer: A systematic review and meta-analysis - Cancer Treatment Reviews
